# Vesugen

*Also known as: Vesugen*

Peptide bioregulator researched for vascular wall and cardiovascular support.

## Overview

Vesugen is a peptide bioregulator from Khavinson's cytogen series, intended to support the vascular wall and cardiovascular system. It is proposed to regulate gene expression in vascular tissue, though the molecular target is not well characterized and no classical receptor has been identified. The half-life is short and human pharmacokinetics have not been established. The supporting literature comes almost entirely from the originating Russian research group, with limited independent replication and no large randomized trials for cardiovascular endpoints. Values shown in the plotter are illustrative estimates based on analogous small peptides rather than measured human PK, and should be read as research context only.

## Pharmacokinetics

- **Model tier:** simple
- **Half-life:** 0.2 days (4.08 hours)
- **Bioavailability:** 40%

## Dosing

- **Default dose:** 1 mg
- **Typical range:** 0.5–2 mg
- **Units:** ng/mL

## Source

- **Label:** Estimated (bioregulator)
- **Notes:** Vascular-wall peptide bioregulator.

**Tags:** anti-aging-longevity, recovery-healing

---

**Canonical URL:** https://anabolicdex.com/compounds/vesugen
**Plot:** https://anabolicdex.com/plot?compound=vesugen